These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju. Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608 [TBL] [Abstract][Full Text] [Related]
23. Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan. Wu PS; Chang LY; Lin HC; Chi H; Hsieh YC; Huang YC; Liu CC; Huang YC; Huang LM Pediatr Pulmonol; 2013 Sep; 48(9):904-11. PubMed ID: 23169584 [TBL] [Abstract][Full Text] [Related]
24. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure. Cheong KN; Chiu SS; Chan BW; To KK; Chan EL; Ho PL J Microbiol Immunol Infect; 2016 Feb; 49(1):127-30. PubMed ID: 25556047 [TBL] [Abstract][Full Text] [Related]
25. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515 [TBL] [Abstract][Full Text] [Related]
26. A Case of Macrolide-Refractory Matsuda Y; Chigusa Y; Kondoh E; Ito I; Ueda Y; Mandai M Case Rep Obstet Gynecol; 2017; 2017():3520192. PubMed ID: 29375919 [TBL] [Abstract][Full Text] [Related]
27. Clonal Expansion of Macrolide-Resistant Sequence Type 3 Mycoplasma pneumoniae, South Korea. Lee JK; Lee JH; Lee H; Ahn YM; Eun BW; Cho EY; Cho HJ; Yun KW; Lee HJ; Choi EH Emerg Infect Dis; 2018 Aug; 24(8):1465-1471. PubMed ID: 30014844 [TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics and Antibiotic Resistance of Mycoplasma Pneumoniae Pneumonia in Hospitalized Chinese Children. Yuan C; Min FM; Ling YJ; Li G; Ye HZ; Pan JH; Wang L; Xie YP Comb Chem High Throughput Screen; 2018; 21(10):749-754. PubMed ID: 30636596 [TBL] [Abstract][Full Text] [Related]
29. [Servere atypical pneumonia with macrolide-resistant Mycoplasma pneumoniae]. Bruno Pedersen AS; Østergaard L; Jespersen S Ugeskr Laeger; 2018 Jul; 180(30):. PubMed ID: 30037385 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of resistance acquisition and treatment of macrolide-resistant Yang HJ; Song DJ; Shim JY Korean J Pediatr; 2017 Jun; 60(6):167-174. PubMed ID: 28690643 [No Abstract] [Full Text] [Related]
31. Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015. Brown RJ; Macfarlane-Smith L; Phillips S; Chalker VJ Euro Surveill; 2015; 20(48):30078. PubMed ID: 26675545 [TBL] [Abstract][Full Text] [Related]
32. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China]. Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430 [TBL] [Abstract][Full Text] [Related]
34. [A Study on the Clinical Course and Antimicrobial Susceptibility of Mycoplasma pneumoniae in a Community Hospital]. Sakai T; Ishida T; Arita M; Tachibana H; Yoshioka H; Noyama M; Tokioka F; Ito A; Furuta K; Nishiyama A; Hashimoto T; Fujii H; Nakajima H; Kenri T; Shibayama K Kansenshogaku Zasshi; 2015 Jul; 89(4):458-64. PubMed ID: 26554221 [TBL] [Abstract][Full Text] [Related]
35. Community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in adults. Hanada S; Morozumi M; Takahashi Y; Mochizuki S; Sato T; Suzuki S; Uruga H; Takaya H; Miyamoto A; Morokawa N; Ubukata K; Kishi K Intern Med; 2014; 53(15):1675-8. PubMed ID: 25088885 [TBL] [Abstract][Full Text] [Related]
36. First detection and characterization of macrolide-resistant Mycoplasma pneumoniae strains in Cuba. Rodriguez N; Mondeja B; Sardiñas R; Vega D; Dumke R Int J Infect Dis; 2019 Mar; 80():115-117. PubMed ID: 30634044 [TBL] [Abstract][Full Text] [Related]
37. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. Matsubara K; Morozumi M; Okada T; Matsushima T; Komiyama O; Shoji M; Ebihara T; Ubukata K; Sato Y; Akita H; Sunakawa K; Iwata S J Infect Chemother; 2009 Dec; 15(6):380-3. PubMed ID: 20012728 [TBL] [Abstract][Full Text] [Related]
38. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Mulholland S; Gavranich JB; Gillies MB; Chang AB Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079 [TBL] [Abstract][Full Text] [Related]
39. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Mulholland S; Gavranich JB; Chang AB Cochrane Database Syst Rev; 2010 Jul; (7):CD004875. PubMed ID: 20614439 [TBL] [Abstract][Full Text] [Related]
40. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. Waites KB; Ratliff A; Crabb DM; Xiao L; Qin X; Selvarangan R; Tang YW; Zheng X; Dien Bard J; Hong T; Prichard M; Brooks E; Dallas S; Duffy L; Mixon E; Fowler KB; Atkinson TP J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31484701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]